nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCB1—ovarian cancer	0.212	1	CbGaD
Pitavastatin—SLCO1B3—Paclitaxel—ovarian cancer	0.078	0.123	CbGbCtD
Pitavastatin—UGT2B7—Epirubicin—ovarian cancer	0.0769	0.121	CbGbCtD
Pitavastatin—ABCG2—Topotecan—ovarian cancer	0.0729	0.115	CbGbCtD
Pitavastatin—SLCO1B3—Docetaxel—ovarian cancer	0.0564	0.0889	CbGbCtD
Pitavastatin—ABCC2—Paclitaxel—ovarian cancer	0.0399	0.0629	CbGbCtD
Pitavastatin—ABCC2—Carboplatin—ovarian cancer	0.0375	0.0592	CbGbCtD
Pitavastatin—ABCG2—Paclitaxel—ovarian cancer	0.0361	0.0569	CbGbCtD
Pitavastatin—ABCG2—Carboplatin—ovarian cancer	0.0339	0.0535	CbGbCtD
Pitavastatin—ABCC2—Docetaxel—ovarian cancer	0.0288	0.0455	CbGbCtD
Pitavastatin—ABCB1—Topotecan—ovarian cancer	0.0263	0.0414	CbGbCtD
Pitavastatin—ABCG2—Docetaxel—ovarian cancer	0.0261	0.0411	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—ovarian cancer	0.0215	0.0339	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—ovarian cancer	0.0194	0.0307	CbGbCtD
Pitavastatin—CYP2C8—Paclitaxel—ovarian cancer	0.0192	0.0303	CbGbCtD
Pitavastatin—ABCB1—Vinorelbine—ovarian cancer	0.0185	0.0292	CbGbCtD
Pitavastatin—CYP2C9—Paclitaxel—ovarian cancer	0.0134	0.0211	CbGbCtD
Pitavastatin—ABCB1—Paclitaxel—ovarian cancer	0.013	0.0205	CbGbCtD
Pitavastatin—ABCB1—Docetaxel—ovarian cancer	0.0094	0.0148	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—ovarian cancer	0.00701	0.0111	CbGbCtD
Pitavastatin—Interstitial lung disease—Chlorambucil—ovarian cancer	0.00205	0.0283	CcSEcCtD
Pitavastatin—Interstitial lung disease—Topotecan—ovarian cancer	0.00183	0.0252	CcSEcCtD
Pitavastatin—Interstitial lung disease—Melphalan—ovarian cancer	0.00179	0.0247	CcSEcCtD
Pitavastatin—HMGCR—myometrium—ovarian cancer	0.00157	0.0366	CbGeAlD
Pitavastatin—SLC10A1—gonad—ovarian cancer	0.00148	0.0346	CbGeAlD
Pitavastatin—Rhabdomyolysis—Melphalan—ovarian cancer	0.00143	0.0197	CcSEcCtD
Pitavastatin—SLCO1B3—vagina—ovarian cancer	0.00137	0.032	CbGeAlD
Pitavastatin—SLC10A1—female reproductive system—ovarian cancer	0.00132	0.0309	CbGeAlD
Pitavastatin—Fatigue—Altretamine—ovarian cancer	0.00126	0.0173	CcSEcCtD
Pitavastatin—UGT2B7—female reproductive system—ovarian cancer	0.00124	0.0289	CbGeAlD
Pitavastatin—HMGCR—epithelium—ovarian cancer	0.00123	0.0288	CbGeAlD
Pitavastatin—HMGCR—uterine cervix—ovarian cancer	0.00122	0.0285	CbGeAlD
Pitavastatin—HMGCR—decidua—ovarian cancer	0.00117	0.0272	CbGeAlD
Pitavastatin—Renal failure acute—Chlorambucil—ovarian cancer	0.00114	0.0158	CcSEcCtD
Pitavastatin—HMGCR—endometrium—ovarian cancer	0.00111	0.0258	CbGeAlD
Pitavastatin—SLC10A1—testis—ovarian cancer	0.00107	0.0249	CbGeAlD
Pitavastatin—Interstitial lung disease—Paclitaxel—ovarian cancer	0.00105	0.0145	CcSEcCtD
Pitavastatin—Asthenia—Altretamine—ovarian cancer	0.00105	0.0144	CcSEcCtD
Pitavastatin—HMGCR—gonad—ovarian cancer	0.00103	0.0239	CbGeAlD
Pitavastatin—HMGCR—uterus—ovarian cancer	0.00102	0.0238	CbGeAlD
Pitavastatin—UGT2B7—testis—ovarian cancer	0.001	0.0233	CbGeAlD
Pitavastatin—Renal failure acute—Melphalan—ovarian cancer	0.000995	0.0137	CcSEcCtD
Pitavastatin—SLCO2B1—decidua—ovarian cancer	0.000987	0.023	CbGeAlD
Pitavastatin—ORM1—endometrium—ovarian cancer	0.000978	0.0228	CbGeAlD
Pitavastatin—Dizziness—Altretamine—ovarian cancer	0.000964	0.0133	CcSEcCtD
Pitavastatin—HMGCR—female reproductive system—ovarian cancer	0.000916	0.0214	CbGeAlD
Pitavastatin—Hepatic failure—Vinorelbine—ovarian cancer	0.000893	0.0123	CcSEcCtD
Pitavastatin—Interstitial lung disease—Docetaxel—ovarian cancer	0.000891	0.0123	CcSEcCtD
Pitavastatin—SLCO1B1—female reproductive system—ovarian cancer	0.000878	0.0205	CbGeAlD
Pitavastatin—Myositis—Epirubicin—ovarian cancer	0.000867	0.012	CcSEcCtD
Pitavastatin—Nausea—Altretamine—ovarian cancer	0.000866	0.0119	CcSEcCtD
Pitavastatin—HMGCR—bone marrow—ovarian cancer	0.000865	0.0202	CbGeAlD
Pitavastatin—SLCO2B1—uterus—ovarian cancer	0.000863	0.0201	CbGeAlD
Pitavastatin—HMGCR—female gonad—ovarian cancer	0.000834	0.0194	CbGeAlD
Pitavastatin—ABCG2—myometrium—ovarian cancer	0.000832	0.0194	CbGeAlD
Pitavastatin—HMGCR—vagina—ovarian cancer	0.000829	0.0193	CbGeAlD
Pitavastatin—ORM1—female reproductive system—ovarian cancer	0.00081	0.0189	CbGeAlD
Pitavastatin—Myositis—Doxorubicin—ovarian cancer	0.000802	0.0111	CcSEcCtD
Pitavastatin—Jaundice—Chlorambucil—ovarian cancer	0.000792	0.0109	CcSEcCtD
Pitavastatin—SLCO2B1—female reproductive system—ovarian cancer	0.000776	0.0181	CbGeAlD
Pitavastatin—ORM1—bone marrow—ovarian cancer	0.000765	0.0178	CbGeAlD
Pitavastatin—HMGCR—testis—ovarian cancer	0.000739	0.0172	CbGeAlD
Pitavastatin—SLCO2B1—female gonad—ovarian cancer	0.000706	0.0165	CbGeAlD
Pitavastatin—Jaundice—Melphalan—ovarian cancer	0.00069	0.00952	CcSEcCtD
Pitavastatin—ABCC2—female reproductive system—ovarian cancer	0.000665	0.0155	CbGeAlD
Pitavastatin—ABCG2—uterine cervix—ovarian cancer	0.000648	0.0151	CbGeAlD
Pitavastatin—Hypoaesthesia—Topotecan—ovarian cancer	0.000646	0.00891	CcSEcCtD
Pitavastatin—Hepatitis—Melphalan—ovarian cancer	0.000636	0.00877	CcSEcCtD
Pitavastatin—SLCO2B1—testis—ovarian cancer	0.000626	0.0146	CbGeAlD
Pitavastatin—ABCG2—decidua—ovarian cancer	0.000617	0.0144	CbGeAlD
Pitavastatin—CYP2C8—endometrium—ovarian cancer	0.000602	0.014	CbGeAlD
Pitavastatin—ABCG2—endometrium—ovarian cancer	0.000586	0.0137	CbGeAlD
Pitavastatin—Renal failure acute—Paclitaxel—ovarian cancer	0.000585	0.00807	CcSEcCtD
Pitavastatin—ALB—testis—ovarian cancer	0.000573	0.0134	CbGeAlD
Pitavastatin—Hypoaesthesia—Vinorelbine—ovarian cancer	0.000552	0.00762	CcSEcCtD
Pitavastatin—Back pain—Topotecan—ovarian cancer	0.000547	0.00754	CcSEcCtD
Pitavastatin—Muscle spasms—Topotecan—ovarian cancer	0.000543	0.0075	CcSEcCtD
Pitavastatin—Pain in extremity—Paclitaxel—ovarian cancer	0.00054	0.00745	CcSEcCtD
Pitavastatin—ABCG2—uterus—ovarian cancer	0.00054	0.0126	CbGeAlD
Pitavastatin—ABCC2—testis—ovarian cancer	0.000537	0.0125	CbGeAlD
Pitavastatin—HMGCR—lymph node—ovarian cancer	0.000536	0.0125	CbGeAlD
Pitavastatin—Ill-defined disorder—Topotecan—ovarian cancer	0.000524	0.00723	CcSEcCtD
Pitavastatin—Confusional state—Chlorambucil—ovarian cancer	0.000522	0.00721	CcSEcCtD
Pitavastatin—Malaise—Topotecan—ovarian cancer	0.00051	0.00703	CcSEcCtD
Pitavastatin—Hepatic failure—Docetaxel—ovarian cancer	0.000509	0.00703	CcSEcCtD
Pitavastatin—CYP2C8—female reproductive system—ovarian cancer	0.000499	0.0116	CbGeAlD
Pitavastatin—Nasopharyngitis—Paclitaxel—ovarian cancer	0.000483	0.00666	CcSEcCtD
Pitavastatin—Arthralgia—Topotecan—ovarian cancer	0.000481	0.00664	CcSEcCtD
Pitavastatin—Myalgia—Topotecan—ovarian cancer	0.000481	0.00664	CcSEcCtD
Pitavastatin—Discomfort—Topotecan—ovarian cancer	0.000475	0.00656	CcSEcCtD
Pitavastatin—ORM1—lymph node—ovarian cancer	0.000474	0.011	CbGeAlD
Pitavastatin—Myalgia—Melphalan—ovarian cancer	0.000471	0.0065	CcSEcCtD
Pitavastatin—Back pain—Vinorelbine—ovarian cancer	0.000468	0.00645	CcSEcCtD
Pitavastatin—Influenza—Paclitaxel—ovarian cancer	0.000467	0.00644	CcSEcCtD
Pitavastatin—ABCG2—bone marrow—ovarian cancer	0.000458	0.0107	CbGeAlD
Pitavastatin—Pain in extremity—Docetaxel—ovarian cancer	0.000458	0.00631	CcSEcCtD
Pitavastatin—Dyspepsia—Chlorambucil—ovarian cancer	0.000456	0.00629	CcSEcCtD
Pitavastatin—SLCO2B1—lymph node—ovarian cancer	0.000454	0.0106	CbGeAlD
Pitavastatin—CYP2C8—vagina—ovarian cancer	0.000451	0.0105	CbGeAlD
Pitavastatin—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000448	0.00619	CcSEcCtD
Pitavastatin—Fatigue—Chlorambucil—ovarian cancer	0.000447	0.00616	CcSEcCtD
Pitavastatin—CYP2C9—female reproductive system—ovarian cancer	0.000443	0.0103	CbGeAlD
Pitavastatin—ABCG2—female gonad—ovarian cancer	0.000442	0.0103	CbGeAlD
Pitavastatin—ABCG2—vagina—ovarian cancer	0.000439	0.0102	CbGeAlD
Pitavastatin—Malaise—Vinorelbine—ovarian cancer	0.000436	0.00601	CcSEcCtD
Pitavastatin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000427	0.00589	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000424	0.00584	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00042	0.0058	CcSEcCtD
Pitavastatin—ALB—lymph node—ovarian cancer	0.000415	0.00968	CbGeAlD
Pitavastatin—Urticaria—Chlorambucil—ovarian cancer	0.000412	0.00568	CcSEcCtD
Pitavastatin—Myalgia—Vinorelbine—ovarian cancer	0.000411	0.00568	CcSEcCtD
Pitavastatin—Arthralgia—Vinorelbine—ovarian cancer	0.000411	0.00568	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000411	0.00568	CcSEcCtD
Pitavastatin—ABCB1—myometrium—ovarian cancer	0.00041	0.00957	CbGeAlD
Pitavastatin—Abdominal pain—Chlorambucil—ovarian cancer	0.000409	0.00565	CcSEcCtD
Pitavastatin—Nasopharyngitis—Docetaxel—ovarian cancer	0.000409	0.00565	CcSEcCtD
Pitavastatin—Discomfort—Vinorelbine—ovarian cancer	0.000407	0.00561	CcSEcCtD
Pitavastatin—Dyspepsia—Topotecan—ovarian cancer	0.000406	0.0056	CcSEcCtD
Pitavastatin—CYP2C8—testis—ovarian cancer	0.000403	0.00939	CbGeAlD
Pitavastatin—Fatigue—Topotecan—ovarian cancer	0.000398	0.00549	CcSEcCtD
Pitavastatin—Dyspepsia—Melphalan—ovarian cancer	0.000397	0.00548	CcSEcCtD
Pitavastatin—ABCB1—embryo—ovarian cancer	0.000395	0.0092	CbGeAlD
Pitavastatin—Constipation—Topotecan—ovarian cancer	0.000394	0.00544	CcSEcCtD
Pitavastatin—ABCG2—testis—ovarian cancer	0.000392	0.00913	CbGeAlD
Pitavastatin—Fatigue—Melphalan—ovarian cancer	0.000389	0.00537	CcSEcCtD
Pitavastatin—ABCC2—lymph node—ovarian cancer	0.000389	0.00907	CbGeAlD
Pitavastatin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000382	0.00527	CcSEcCtD
Pitavastatin—Feeling abnormal—Topotecan—ovarian cancer	0.00038	0.00524	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000377	0.0052	CcSEcCtD
Pitavastatin—Asthenia—Chlorambucil—ovarian cancer	0.000372	0.00513	CcSEcCtD
Pitavastatin—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000372	0.00513	CcSEcCtD
Pitavastatin—Pruritus—Chlorambucil—ovarian cancer	0.000366	0.00506	CcSEcCtD
Pitavastatin—Urticaria—Topotecan—ovarian cancer	0.000366	0.00505	CcSEcCtD
Pitavastatin—Abdominal pain—Topotecan—ovarian cancer	0.000365	0.00503	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000359	0.00496	CcSEcCtD
Pitavastatin—Urticaria—Melphalan—ovarian cancer	0.000359	0.00495	CcSEcCtD
Pitavastatin—Diarrhoea—Chlorambucil—ovarian cancer	0.000354	0.00489	CcSEcCtD
Pitavastatin—Jaundice—Docetaxel—ovarian cancer	0.000344	0.00474	CcSEcCtD
Pitavastatin—Hepatic failure—Epirubicin—ovarian cancer	0.000343	0.00474	CcSEcCtD
Pitavastatin—Fatigue—Vinorelbine—ovarian cancer	0.00034	0.00469	CcSEcCtD
Pitavastatin—Hypersensitivity—Topotecan—ovarian cancer	0.00034	0.00469	CcSEcCtD
Pitavastatin—Constipation—Vinorelbine—ovarian cancer	0.000337	0.00465	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—ovarian cancer	0.000334	0.00461	CcSEcCtD
Pitavastatin—Hypersensitivity—Melphalan—ovarian cancer	0.000333	0.00459	CcSEcCtD
Pitavastatin—Asthenia—Topotecan—ovarian cancer	0.000331	0.00457	CcSEcCtD
Pitavastatin—Pruritus—Topotecan—ovarian cancer	0.000326	0.0045	CcSEcCtD
Pitavastatin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000325	0.00449	CcSEcCtD
Pitavastatin—Asthenia—Melphalan—ovarian cancer	0.000324	0.00447	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000323	0.00445	CcSEcCtD
Pitavastatin—ABCB1—epithelium—ovarian cancer	0.000322	0.00751	CbGeAlD
Pitavastatin—Pruritus—Melphalan—ovarian cancer	0.000319	0.00441	CcSEcCtD
Pitavastatin—ABCB1—uterine cervix—ovarian cancer	0.000319	0.00745	CbGeAlD
Pitavastatin—Hepatic failure—Doxorubicin—ovarian cancer	0.000318	0.00438	CcSEcCtD
Pitavastatin—Hepatitis—Docetaxel—ovarian cancer	0.000317	0.00437	CcSEcCtD
Pitavastatin—Diarrhoea—Topotecan—ovarian cancer	0.000316	0.00435	CcSEcCtD
Pitavastatin—Hypoaesthesia—Docetaxel—ovarian cancer	0.000315	0.00435	CcSEcCtD
Pitavastatin—Back pain—Paclitaxel—ovarian cancer	0.000314	0.00434	CcSEcCtD
Pitavastatin—Urticaria—Vinorelbine—ovarian cancer	0.000313	0.00432	CcSEcCtD
Pitavastatin—Muscle spasms—Paclitaxel—ovarian cancer	0.000313	0.00431	CcSEcCtD
Pitavastatin—Abdominal pain—Vinorelbine—ovarian cancer	0.000312	0.0043	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—ovarian cancer	0.000309	0.00427	CcSEcCtD
Pitavastatin—Diarrhoea—Melphalan—ovarian cancer	0.000309	0.00426	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—ovarian cancer	0.000309	0.00426	CcSEcCtD
Pitavastatin—Nausea—Chlorambucil—ovarian cancer	0.000308	0.00425	CcSEcCtD
Pitavastatin—Dizziness—Topotecan—ovarian cancer	0.000305	0.00421	CcSEcCtD
Pitavastatin—ABCB1—decidua—ovarian cancer	0.000304	0.00709	CbGeAlD
Pitavastatin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000302	0.00416	CcSEcCtD
Pitavastatin—Malaise—Paclitaxel—ovarian cancer	0.000293	0.00405	CcSEcCtD
Pitavastatin—Rash—Topotecan—ovarian cancer	0.000291	0.00401	CcSEcCtD
Pitavastatin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000291	0.00401	CcSEcCtD
Pitavastatin—Dermatitis—Topotecan—ovarian cancer	0.00029	0.00401	CcSEcCtD
Pitavastatin—Headache—Topotecan—ovarian cancer	0.000289	0.00399	CcSEcCtD
Pitavastatin—ABCB1—endometrium—ovarian cancer	0.000289	0.00673	CbGeAlD
Pitavastatin—Pain in extremity—Doxorubicin—ovarian cancer	0.000286	0.00394	CcSEcCtD
Pitavastatin—Rash—Melphalan—ovarian cancer	0.000285	0.00393	CcSEcCtD
Pitavastatin—Dermatitis—Melphalan—ovarian cancer	0.000284	0.00392	CcSEcCtD
Pitavastatin—ABCG2—lymph node—ovarian cancer	0.000284	0.00662	CbGeAlD
Pitavastatin—Asthenia—Vinorelbine—ovarian cancer	0.000283	0.00391	CcSEcCtD
Pitavastatin—Pruritus—Vinorelbine—ovarian cancer	0.000279	0.00385	CcSEcCtD
Pitavastatin—Arthralgia—Paclitaxel—ovarian cancer	0.000277	0.00382	CcSEcCtD
Pitavastatin—Myalgia—Paclitaxel—ovarian cancer	0.000277	0.00382	CcSEcCtD
Pitavastatin—Nasopharyngitis—Epirubicin—ovarian cancer	0.000276	0.00381	CcSEcCtD
Pitavastatin—Nausea—Topotecan—ovarian cancer	0.000274	0.00378	CcSEcCtD
Pitavastatin—Discomfort—Paclitaxel—ovarian cancer	0.000273	0.00377	CcSEcCtD
Pitavastatin—Diarrhoea—Vinorelbine—ovarian cancer	0.00027	0.00372	CcSEcCtD
Pitavastatin—Nausea—Melphalan—ovarian cancer	0.000268	0.0037	CcSEcCtD
Pitavastatin—ABCB1—gonad—ovarian cancer	0.000268	0.00625	CbGeAlD
Pitavastatin—Confusional state—Paclitaxel—ovarian cancer	0.000268	0.00369	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—ovarian cancer	0.000267	0.00368	CcSEcCtD
Pitavastatin—Back pain—Docetaxel—ovarian cancer	0.000267	0.00368	CcSEcCtD
Pitavastatin—ABCB1—uterus—ovarian cancer	0.000266	0.00621	CbGeAlD
Pitavastatin—Muscle spasms—Docetaxel—ovarian cancer	0.000265	0.00366	CcSEcCtD
Pitavastatin—Dizziness—Vinorelbine—ovarian cancer	0.000261	0.0036	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000255	0.00352	CcSEcCtD
Pitavastatin—Rash—Vinorelbine—ovarian cancer	0.000249	0.00343	CcSEcCtD
Pitavastatin—Dermatitis—Vinorelbine—ovarian cancer	0.000248	0.00343	CcSEcCtD
Pitavastatin—Headache—Vinorelbine—ovarian cancer	0.000247	0.00341	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—ovarian cancer	0.000247	0.00341	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000242	0.00334	CcSEcCtD
Pitavastatin—Insomnia—Paclitaxel—ovarian cancer	0.00024	0.00331	CcSEcCtD
Pitavastatin—ABCB1—female reproductive system—ovarian cancer	0.000239	0.00558	CbGeAlD
Pitavastatin—Arthralgia—Docetaxel—ovarian cancer	0.000235	0.00324	CcSEcCtD
Pitavastatin—Myalgia—Docetaxel—ovarian cancer	0.000235	0.00324	CcSEcCtD
Pitavastatin—Nausea—Vinorelbine—ovarian cancer	0.000234	0.00323	CcSEcCtD
Pitavastatin—Dyspepsia—Paclitaxel—ovarian cancer	0.000234	0.00322	CcSEcCtD
Pitavastatin—Jaundice—Epirubicin—ovarian cancer	0.000232	0.0032	CcSEcCtD
Pitavastatin—Fatigue—Paclitaxel—ovarian cancer	0.000229	0.00316	CcSEcCtD
Pitavastatin—Constipation—Paclitaxel—ovarian cancer	0.000227	0.00313	CcSEcCtD
Pitavastatin—Confusional state—Docetaxel—ovarian cancer	0.000227	0.00313	CcSEcCtD
Pitavastatin—ABCB1—bone marrow—ovarian cancer	0.000226	0.00527	CbGeAlD
Pitavastatin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000219	0.00302	CcSEcCtD
Pitavastatin—ABCB1—female gonad—ovarian cancer	0.000218	0.00508	CbGeAlD
Pitavastatin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000217	0.00299	CcSEcCtD
Pitavastatin—ABCB1—vagina—ovarian cancer	0.000216	0.00504	CbGeAlD
Pitavastatin—Jaundice—Doxorubicin—ovarian cancer	0.000215	0.00296	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—ovarian cancer	0.000214	0.00295	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000212	0.00293	CcSEcCtD
Pitavastatin—Urticaria—Paclitaxel—ovarian cancer	0.000211	0.00291	CcSEcCtD
Pitavastatin—Abdominal pain—Paclitaxel—ovarian cancer	0.00021	0.00289	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000205	0.00283	CcSEcCtD
Pitavastatin—Insomnia—Docetaxel—ovarian cancer	0.000203	0.00281	CcSEcCtD
Pitavastatin—Dyspepsia—Docetaxel—ovarian cancer	0.000198	0.00273	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—ovarian cancer	0.000198	0.00273	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000197	0.00271	CcSEcCtD
Pitavastatin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000195	0.0027	CcSEcCtD
Pitavastatin—Fatigue—Docetaxel—ovarian cancer	0.000194	0.00268	CcSEcCtD
Pitavastatin—ABCB1—testis—ovarian cancer	0.000193	0.0045	CbGeAlD
Pitavastatin—Constipation—Docetaxel—ovarian cancer	0.000192	0.00265	CcSEcCtD
Pitavastatin—Asthenia—Paclitaxel—ovarian cancer	0.00019	0.00263	CcSEcCtD
Pitavastatin—Pruritus—Paclitaxel—ovarian cancer	0.000188	0.00259	CcSEcCtD
Pitavastatin—Feeling abnormal—Docetaxel—ovarian cancer	0.000185	0.00256	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000184	0.00254	CcSEcCtD
Pitavastatin—Diarrhoea—Paclitaxel—ovarian cancer	0.000182	0.0025	CcSEcCtD
Pitavastatin—Back pain—Epirubicin—ovarian cancer	0.00018	0.00248	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—ovarian cancer	0.000179	0.00247	CcSEcCtD
Pitavastatin—Abdominal pain—Docetaxel—ovarian cancer	0.000178	0.00245	CcSEcCtD
Pitavastatin—Dizziness—Paclitaxel—ovarian cancer	0.000175	0.00242	CcSEcCtD
Pitavastatin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000172	0.00238	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—ovarian cancer	0.000168	0.00231	CcSEcCtD
Pitavastatin—Rash—Paclitaxel—ovarian cancer	0.000167	0.00231	CcSEcCtD
Pitavastatin—Dermatitis—Paclitaxel—ovarian cancer	0.000167	0.00231	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—ovarian cancer	0.000166	0.0023	CcSEcCtD
Pitavastatin—Headache—Paclitaxel—ovarian cancer	0.000166	0.00229	CcSEcCtD
Pitavastatin—Hypersensitivity—Docetaxel—ovarian cancer	0.000166	0.00229	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—ovarian cancer	0.000165	0.00228	CcSEcCtD
Pitavastatin—Asthenia—Docetaxel—ovarian cancer	0.000161	0.00223	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00016	0.0022	CcSEcCtD
Pitavastatin—Pruritus—Docetaxel—ovarian cancer	0.000159	0.0022	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—ovarian cancer	0.000158	0.00218	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—ovarian cancer	0.000158	0.00218	CcSEcCtD
Pitavastatin—Nausea—Paclitaxel—ovarian cancer	0.000158	0.00217	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—ovarian cancer	0.000156	0.00216	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—ovarian cancer	0.000155	0.00214	CcSEcCtD
Pitavastatin—Diarrhoea—Docetaxel—ovarian cancer	0.000154	0.00212	CcSEcCtD
Pitavastatin—Confusional state—Epirubicin—ovarian cancer	0.000153	0.00211	CcSEcCtD
Pitavastatin—Dizziness—Docetaxel—ovarian cancer	0.000149	0.00205	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—ovarian cancer	0.000146	0.00202	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—ovarian cancer	0.000146	0.00202	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—ovarian cancer	0.000145	0.002	CcSEcCtD
Pitavastatin—Rash—Docetaxel—ovarian cancer	0.000142	0.00196	CcSEcCtD
Pitavastatin—Dermatitis—Docetaxel—ovarian cancer	0.000142	0.00195	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—ovarian cancer	0.000142	0.00195	CcSEcCtD
Pitavastatin—Headache—Docetaxel—ovarian cancer	0.000141	0.00194	CcSEcCtD
Pitavastatin—ABCB1—lymph node—ovarian cancer	0.00014	0.00326	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000138	0.00191	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—ovarian cancer	0.000137	0.00189	CcSEcCtD
Pitavastatin—Nausea—Docetaxel—ovarian cancer	0.000134	0.00184	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—ovarian cancer	0.000134	0.00184	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—ovarian cancer	0.000131	0.0018	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—ovarian cancer	0.00013	0.00179	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000128	0.00176	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—ovarian cancer	0.000127	0.00175	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—ovarian cancer	0.000125	0.00172	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000124	0.00171	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—ovarian cancer	0.000124	0.0017	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—ovarian cancer	0.000121	0.00167	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—ovarian cancer	0.000121	0.00166	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—ovarian cancer	0.00012	0.00166	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—ovarian cancer	0.00012	0.00165	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000116	0.0016	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000115	0.00158	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—ovarian cancer	0.000112	0.00154	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—ovarian cancer	0.000112	0.00154	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—ovarian cancer	0.000111	0.00153	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—ovarian cancer	0.000109	0.0015	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—ovarian cancer	0.000107	0.00148	CcSEcCtD
Pitavastatin—Diarrhoea—Epirubicin—ovarian cancer	0.000104	0.00143	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000103	0.00143	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—ovarian cancer	0.000101	0.00139	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—ovarian cancer	0.0001	0.00138	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—ovarian cancer	9.93e-05	0.00137	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—ovarian cancer	9.6e-05	0.00133	CcSEcCtD
Pitavastatin—Rash—Epirubicin—ovarian cancer	9.56e-05	0.00132	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—ovarian cancer	9.56e-05	0.00132	CcSEcCtD
Pitavastatin—Headache—Epirubicin—ovarian cancer	9.5e-05	0.00131	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—ovarian cancer	9.28e-05	0.00128	CcSEcCtD
Pitavastatin—Nausea—Epirubicin—ovarian cancer	9.01e-05	0.00124	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—ovarian cancer	8.85e-05	0.00122	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—ovarian cancer	8.84e-05	0.00122	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—ovarian cancer	8.79e-05	0.00121	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—ovarian cancer	8.34e-05	0.00115	CcSEcCtD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.4e-05	0.00062	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SPARC—ovarian cancer	2.39e-05	0.00062	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.39e-05	0.00062	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PPP2R1A—ovarian cancer	2.38e-05	0.000616	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.37e-05	0.000613	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SLC5A5—ovarian cancer	2.36e-05	0.000612	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.34e-05	0.000606	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NME2—ovarian cancer	2.31e-05	0.000598	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SLC2A1—ovarian cancer	2.28e-05	0.000591	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—FASN—ovarian cancer	2.26e-05	0.000586	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.25e-05	0.000584	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	2.25e-05	0.000582	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	2.23e-05	0.000576	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.21e-05	0.000573	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ABCB1—ovarian cancer	2.21e-05	0.000572	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP1B1—ovarian cancer	2.19e-05	0.000566	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—TYMS—ovarian cancer	2.17e-05	0.000562	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	2.15e-05	0.000557	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CAV1—ovarian cancer	2.15e-05	0.000555	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.11e-05	0.000545	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	2.06e-05	0.000534	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.05e-05	0.000531	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—FASN—ovarian cancer	2.04e-05	0.000529	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.03e-05	0.000525	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SLC5A5—ovarian cancer	2.01e-05	0.00052	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.98e-05	0.000512	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	1.98e-05	0.000512	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.96e-05	0.000508	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.96e-05	0.000507	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CG—ovarian cancer	1.95e-05	0.000506	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.95e-05	0.000505	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	1.94e-05	0.000503	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPP2R1A—ovarian cancer	1.94e-05	0.000502	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SLC2A1—ovarian cancer	1.94e-05	0.000502	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—YAP1—ovarian cancer	1.87e-05	0.000483	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP1B1—ovarian cancer	1.86e-05	0.000482	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.85e-05	0.000478	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYTB—ovarian cancer	1.83e-05	0.000473	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	1.83e-05	0.000473	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.82e-05	0.000472	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.82e-05	0.000471	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYTB—ovarian cancer	1.82e-05	0.000471	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ABCB1—ovarian cancer	1.8e-05	0.000466	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.79e-05	0.000463	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.78e-05	0.00046	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—TYMS—ovarian cancer	1.77e-05	0.000458	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.76e-05	0.000456	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CAV1—ovarian cancer	1.75e-05	0.000453	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SOD1—ovarian cancer	1.74e-05	0.00045	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.73e-05	0.000448	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—YAP1—ovarian cancer	1.73e-05	0.000447	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.72e-05	0.000446	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.72e-05	0.000445	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CD—ovarian cancer	1.72e-05	0.000445	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ABCB1—ovarian cancer	1.7e-05	0.000439	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.67e-05	0.000433	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.67e-05	0.000432	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPP2R1A—ovarian cancer	1.65e-05	0.000427	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.62e-05	0.00042	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.6e-05	0.000414	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.6e-05	0.000414	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.6e-05	0.000414	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.6e-05	0.000413	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYTB—ovarian cancer	1.59e-05	0.000412	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CG—ovarian cancer	1.59e-05	0.000412	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.59e-05	0.000412	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPP1CC—ovarian cancer	1.59e-05	0.000411	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BRIP1—ovarian cancer	1.59e-05	0.000411	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.58e-05	0.00041	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.56e-05	0.000404	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.54e-05	0.0004	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ABCB1—ovarian cancer	1.53e-05	0.000397	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—FASN—ovarian cancer	1.52e-05	0.000394	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.52e-05	0.000393	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TYMS—ovarian cancer	1.5e-05	0.000389	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.5e-05	0.000389	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CB—ovarian cancer	1.5e-05	0.000388	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.5e-05	0.000387	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYTB—ovarian cancer	1.49e-05	0.000385	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.47e-05	0.000379	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.45e-05	0.000377	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.44e-05	0.000374	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CAV1—ovarian cancer	1.43e-05	0.000369	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.41e-05	0.000366	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—FASN—ovarian cancer	1.41e-05	0.000365	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CD—ovarian cancer	1.4e-05	0.000363	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.39e-05	0.00036	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BRIP1—ovarian cancer	1.39e-05	0.00036	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.39e-05	0.00036	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.38e-05	0.000359	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.38e-05	0.000359	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.34e-05	0.000348	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.34e-05	0.000348	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.34e-05	0.000346	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.32e-05	0.000343	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.3e-05	0.000337	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.3e-05	0.000337	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CG—ovarian cancer	1.3e-05	0.000336	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTEN—ovarian cancer	1.29e-05	0.000335	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.28e-05	0.000332	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.28e-05	0.000332	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CAV1—ovarian cancer	1.27e-05	0.000329	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.27e-05	0.000329	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.25e-05	0.000324	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.23e-05	0.000318	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.22e-05	0.000317	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.22e-05	0.000316	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CB—ovarian cancer	1.22e-05	0.000316	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.22e-05	0.000315	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CAV1—ovarian cancer	1.21e-05	0.000314	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.21e-05	0.000313	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.19e-05	0.000308	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.19e-05	0.000308	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.16e-05	0.000302	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CG—ovarian cancer	1.16e-05	0.0003	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.16e-05	0.0003	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CD—ovarian cancer	1.14e-05	0.000296	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.14e-05	0.000295	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.14e-05	0.000294	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.13e-05	0.000291	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.12e-05	0.00029	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.1e-05	0.000286	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.08e-05	0.000279	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—YAP1—ovarian cancer	1.07e-05	0.000278	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—YAP1—ovarian cancer	1.07e-05	0.000276	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.06e-05	0.000275	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—ovarian cancer	1.06e-05	0.000273	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.05e-05	0.000273	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—ovarian cancer	1.05e-05	0.000273	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.05e-05	0.000272	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TYMS—ovarian cancer	1.04e-05	0.000269	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.03e-05	0.000268	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CD—ovarian cancer	1.02e-05	0.000264	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1e-05	0.000259	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CB—ovarian cancer	9.95e-06	0.000258	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CD—ovarian cancer	9.71e-06	0.000251	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.48e-06	0.000245	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	9.38e-06	0.000243	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—YAP1—ovarian cancer	9.34e-06	0.000242	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.32e-06	0.000241	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.27e-06	0.00024	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—ovarian cancer	9.13e-06	0.000236	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CAV1—ovarian cancer	9.03e-06	0.000234	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CB—ovarian cancer	8.88e-06	0.00023	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—FASN—ovarian cancer	8.74e-06	0.000226	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—YAP1—ovarian cancer	8.72e-06	0.000226	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—FASN—ovarian cancer	8.69e-06	0.000225	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.63e-06	0.000224	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.62e-06	0.000223	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—ovarian cancer	8.6e-06	0.000223	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC5A5—ovarian cancer	8.59e-06	0.000223	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	8.58e-06	0.000222	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC5A5—ovarian cancer	8.55e-06	0.000221	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CB—ovarian cancer	8.46e-06	0.000219	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.44e-06	0.000219	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CAV1—ovarian cancer	8.36e-06	0.000216	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC2A1—ovarian cancer	8.3e-06	0.000215	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC2A1—ovarian cancer	8.25e-06	0.000214	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	8.22e-06	0.000213	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—ovarian cancer	8.15e-06	0.000211	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.13e-06	0.00021	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—ovarian cancer	8.1e-06	0.00021	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.08e-06	0.000209	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.96e-06	0.000206	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1B1—ovarian cancer	7.91e-06	0.000205	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—FASN—ovarian cancer	7.61e-06	0.000197	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—ovarian cancer	7.61e-06	0.000197	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.59e-06	0.000196	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.49e-06	0.000194	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—ovarian cancer	7.46e-06	0.000193	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—ovarian cancer	7.44e-06	0.000193	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—ovarian cancer	7.31e-06	0.000189	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.23e-06	0.000187	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	7.23e-06	0.000187	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—FASN—ovarian cancer	7.11e-06	0.000184	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	7.06e-06	0.000183	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.02e-06	0.000182	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPP2R1A—ovarian cancer	7.02e-06	0.000182	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.99e-06	0.000181	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.98e-06	0.000181	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.93e-06	0.00018	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—ovarian cancer	6.93e-06	0.000179	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—ovarian cancer	6.84e-06	0.000177	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.76e-06	0.000175	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CD—ovarian cancer	6.69e-06	0.000173	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.61e-06	0.000171	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK3—ovarian cancer	6.55e-06	0.00017	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.55e-06	0.00017	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—ovarian cancer	6.52e-06	0.000169	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.48e-06	0.000168	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TYMS—ovarian cancer	6.44e-06	0.000167	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TYMS—ovarian cancer	6.4e-06	0.000166	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	6.3e-06	0.000163	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK1—ovarian cancer	6.24e-06	0.000161	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.15e-06	0.000159	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—ovarian cancer	6.08e-06	0.000157	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—ovarian cancer	6.06e-06	0.000157	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—ovarian cancer	5.89e-06	0.000153	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.83e-06	0.000151	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.74e-06	0.000149	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.72e-06	0.000148	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	5.72e-06	0.000148	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TYMS—ovarian cancer	5.61e-06	0.000145	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—ovarian cancer	5.44e-06	0.000141	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—ovarian cancer	5.41e-06	0.00014	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.33e-06	0.000138	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TYMS—ovarian cancer	5.24e-06	0.000136	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—ovarian cancer	5.23e-06	0.000136	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CAV1—ovarian cancer	5.19e-06	0.000134	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—ovarian cancer	5.16e-06	0.000134	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CAV1—ovarian cancer	5.16e-06	0.000134	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—ovarian cancer	5.04e-06	0.00013	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—ovarian cancer	5.01e-06	0.00013	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.95e-06	0.000128	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—ovarian cancer	4.95e-06	0.000128	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.93e-06	0.000128	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.72e-06	0.000122	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—ovarian cancer	4.7e-06	0.000122	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—ovarian cancer	4.67e-06	0.000121	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CAV1—ovarian cancer	4.52e-06	0.000117	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—ovarian cancer	4.42e-06	0.000114	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CAV1—ovarian cancer	4.22e-06	0.000109	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—ovarian cancer	4.21e-06	0.000109	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.15e-06	0.000108	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CD—ovarian cancer	4.13e-06	0.000107	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.12e-06	0.000107	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.03e-06	0.000104	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.84e-06	9.95e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	3.84e-06	9.94e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.62e-06	9.37e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.62e-06	9.37e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CB—ovarian cancer	3.6e-06	9.32e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.56e-06	9.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.38e-06	8.75e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.15e-06	8.17e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.14e-06	8.12e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—ovarian cancer	3.13e-06	8.1e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—ovarian cancer	3.11e-06	8.05e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.95e-06	7.63e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—ovarian cancer	2.9e-06	7.52e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—ovarian cancer	2.72e-06	7.06e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—ovarian cancer	2.55e-06	6.59e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.21e-06	5.71e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—ovarian cancer	2.19e-06	5.68e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.92e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—ovarian cancer	1.8e-06	4.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.8e-06	4.65e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—ovarian cancer	1.79e-06	4.64e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—ovarian cancer	1.57e-06	4.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—ovarian cancer	1.47e-06	3.8e-05	CbGpPWpGaD
